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ABSTRACT: A crucial step in the development of therapeutic monoclonal antibodies is the selection of robust pharmaceutical candidates
and screening of efficacious protein formulations to increase the resistance toward physicochemical degradation and aggregation during
processing and storage. Here, we introduce small-angle X-ray scattering (SAXS) to characterize antibody solution behavior, which strongly
complements conventional biophysical analysis. First, we apply a variety of conventional biophysical techniques for the evaluation of
structural, conformational, and colloidal stability and report a systematic comparison between designed humanized IgG1, IgG2, and
IgG4 with identical variable regions. Then, the high information content of SAXS data enables sensitive detection of structural differences
between three IgG subclasses at neutral pH and rapid formation of dimers of IgG2 and IgG4 at low pH. We reveal subclass-specific
variation in intermolecular repulsion already at low and medium protein concentrations, which explains the observed improved stability
of IgG1 with respect to aggregation. We show how excipients dramatically influence such repulsive effects, hence demonstrating the
potential application of extensive SAXS screening in antibody selection, eventual engineering, and formulation development. C© 2014 The
Authors. Journal of Pharmaceutical Sciences published by Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci
103:1701–1710, 2014
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scattering (SAXS)
INTRODUCTION
Immunoglobulin G (IgG) monoclonal antibodies are one of the
largest classes of biopharmaceuticals because of their high anti-
gen specificity and long half-lives in the body. IgG is the most
abundant antibody isotype in blood and external tissue, where
it controls infections of the body.1 The four human IgG sub-
classes IgG1, IgG2, IgG3, and IgG4 account for about 60%,
25%, 10%, and 5% of IgG concentration in blood, respectively.2
Today, more than 20 antibodies are approved for clinical use in
Europe or the United States, and more than 200 are in clinical
development. A majority of the approved antibodies are of the
Abbreviations used: CDR, complementarity-determining region; DLS, dy-
namic light scattering; DSF, differential scanning fluorescence; Dmax, maximal
dimension; Fc, fragment crystallizable; HMWS, high-molecular-weight species;
I(0), scattering intensity at zero angle; iCE, imaged capillary isoelectric focusing;
IgG, immunoglobulin G; LabChip, automated microfluidic SDS electrophore-
sis; LMWS, low-molecular-weight species; mAb, monoclonal antibody; P(r),
pair distance distribution function; Rg, radius of gyration; Rh, hydrodynamic
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IgG1 subclass, whereas there is a greater variation of IgG sub-
class for those in clinical development. Several antibodies have
also been engineered to modify known effector functions.3
In the process of selecting and/or developing therapeutic IgG
monoclonal antibodies, it is important to evaluate the biolog-
ical function and physicochemical characteristics of the IgG
formats. The monoclonal antibodies are susceptible to deterio-
ration during manufacture and storage, which could lead to un-
wanted immune response and decreased bioactivity.4,5 There-
fore, it is crucial to assess the physical and chemical stabil-
ity of antibody proteins including aggregation, fragmentation,
deamidation, and so on at different formulation conditions. Sev-
eral techniques have been developed for physicochemical char-
acterization, and applied in screening for selection and devel-
opment of therapeutic monoclonal antibody (mAb) as well as
for formulation screening. However, limitations of the individ-
ual techniques are recognized. As an example, size-exclusion
HPLC (SE-HPLC) is routinely used in pharmaceutical indus-
try for characterizing aggregation and fragmentation.However,
buffer exchange with themobile phase of SE-HPLC can in some
cases alter the solution behavior of the antibodies. Nonspecific
interactions between the protein sample and the columnmatrix
can also deleteriously affect the results and the conformation
of the protein.6 In addition, another widely used technique,
dynamic light scattering (DLS), exhibits superiority for high-
throughput screening in terms of detecting aggregation. How-
ever, the resolution is relatively low with respect to separation
of different particle populations and the influence of excipients
on the apparent hydrodynamic radius (Rh) has to be addressed.
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Small-angle X-ray scattering (SAXS) has been widely used
for the analysis of biological macromolecules in solution7 and
can monitor the changes of protein conformation,8 transient
protein–protein interactions,9 intermolecular attraction and
repulsion,10 oligomerization, and aggregation.11 Thus, the most
unique feature of SAXS data analysis is the inclusion of infor-
mation about both conformational and colloidal stability. Here,
we introduce SAXS analysis of the solutes in a setup that is
compatible with high-throughput screening, and compare the
readily accessible information content from SAXS data with
a number of well-established methods. We present a system-
atic study of humanized IgG1, IgG2, and IgG4 with identical
variable regions. These proteins have been produced recombi-
nantly and prepared to a high quality with a purity of more
than 99%, enabling direct comparison of the three IgG sub-
classes. Several methods are applied under the same experi-
mental conditions while using the same protein batch for all
analyses. In comparison with conventional techniques, we out-
line the advantages of SAXS analysis and envision the use-
ful application of high-throughput SAXS screening as part of
an efficient and multifaceted strategy on selection and devel-
opment as well as preformulation development of therapeutic
antibodies.
MATERIALS AND METHODS
Materials
The complementarity-determining regions (CDRs) from anti-
TNP (2,4,6-trinitrophenol) mouse mAb were grafted into
human variable regions,12,13 which were then joined to the con-
stant regions of human IgG4. The IgG1 and IgG2 were con-
structed by replacing the constant region of IgG4 heavy chain,
thus the three IgGs have identical light chains and variable
regions of the heavy chain. A single mutation S228P (Kabat
numbering14) was included in the IgG4 heavy chain to prevent
half mAb generation. Double gene constructs were created by
cloning the light chain and heavy chain cDNA into the mam-
malian expression vector pEE14.4 (Lonza Biologics, Auckland,
New Zealand). The stable cell lines were generated by trans-
fecting the recombinant plasmids into CHOK1SV cells (Lonza
Biologics). The antibodies were purified from cell culture su-
pernatants using protein A-based methods and gel filtration
chromatography with identical purification protocols. In order
to monitor the glycosylation patterns, the antibodies were di-
gested by PNGase F, then the released glycans were labeled
with 2-aminobenzamide and analyzed by ACQUITY UPLCR©
System (Waters, Milford, Massachusetts) with BEH Glycan
Separation Technology Column (GST column) coupled to the
fluorescence detector. The purified samples were then formu-
lated at 15–25 mg/mL in phosphate-buffered saline (PBS) at
pH 6.9 and sterile filtered using 0.22 :m polyvinylidene difluo-
ride low-binding-syringe-driven filter units fromMillipore (Car-
rigtwohill, Ireland). Concentrations were determined based on
A280 using theoretical extinction coefficients 14.81 (IgG1), 14.52
(IgG2), and 14.85 (IgG4) (g/100 mL)−1 cm−1, respectively. The
bulk solution was flash frozen in liquid nitrogen and stored at
−80◦C.
Sample preparations particular for each method are de-
scribed in relevant sections, and the experimental conditions,
including formulation buffers and storage conditions, are sum-
marized in Table 1.
Analytical Methods
In this study, we combine conventional biophysical analysis
with high-throughput compatible SAXS-based screening. For
the conventional analysis, we performed (1) an initial screening
of pH and excipients using differential scanning fluorescence
(DSF) and DLS (after storage at 40◦C for 4 days) in a high-
throughput setup; (2) the physical and chemical stability of a
selection of samples (Table 1) was further studied by UV280 nm,
SE-HPLC, and automated microfluidic SDS electrophoresis
(LabChip) under accelerated storage conditions (40◦C); and (3)
two formulations were selected for further studies under nor-
mal storage conditions (5◦C and 25◦C) and characterized by
DLS, SE-HPLC, LabChip, and imaged capillary isoelectric fo-
cusing (iCE). In addition to these conventional analyses, the
solution behavior of antibodies was investigated by SAXS, prior
to any heat stressing and long-term storage. LabChip and iCE
are described in the Supplementary Material.
Differential Scanning Fluorescence
The antibodies were buffer exchanged using illustraTM NAPTM-
5 Columns (GE healthcare, Uppsala, Sweden) into 5 mM histi-
dine, pH 6.5, and the concentration was adjusted to 4 mg/mL
using the same buffer. Before the DSF analysis, the initial
4 mg/mL protein stock was diluted with water to 0.6 mg/mL
and then mixed with an equal volume of buffer stock contain-
ing 5X SYPROR© orange dye, which was supplied as 5000X-
concentrated solutions in dimethyl sulfoxide (Invitrogen, Eu-
gene, Oregon). The final volume of reaction mixtures was 50 :L
in each well. Ninety-six-well optical reaction plates were used
(VWR International, Radnor, Pennsylvania). The fluorescence
signal was detected using aMyiQ single-color real-timePCRde-
tection system (Bio-Rad Labs, Berkeley, California). A 480-nm
excitation filter with 40-nm bandwidth and a 540-nm emission
filter with 50-nm bandwidth were used. Temperature scans
were performed from 25◦C to 90◦C at a scan rate of 1◦C/min,
and thermal transition midpoint (Tm) was determined using
in-house software developed by Novo Nordisk. The unfolding of
an IgG is complex and the individual domains of the conserved
and variable regions unfold independently. For simplicity, we
only present data for the first unfolding transition of each IgG.
This transition represents the unfolding of the CH2 domain in
the fragment crystallizable (Fc) region.15
Dynamic Light Scattering
Samples were prepared in the same manner as for the DSF
analysis, with the difference that before the DLS analysis the
final sample was prepared by mixing 10 :L of protein stock
(4 mg/mL) with 10 :L of a buffer stock (Table 1). All samples
were analyzed at the initial time point and after storage at
40◦C for 4 days. The DLS measurements were carried out in
a 384-well microplate at 25◦C using a Dynapro plate reader
(Wyatt Technology, Goleta, California) equipped with an 831-
nm laser. A total of 10 acquisitions of 5 s each were collected
with auto adjustment of laser power; autoattenuation was ap-
plied. Solvent properties were edited for each sample to adjust
the viscosity and refractive index. All formulation conditions
were studied in duplicate wells. We manually checked the data
quality of each sample according to the fit between correlation
curve and exponential decay function. The Rh, normalized in-
tensity, and polydispersity were calculated from the correlation
function using DYNAMICS 7 (Wyatt Technology).
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Table 1. Summary of the Formulation Conditions
Base Buffera pHb Excipientc Storage Conditions Methods
Initial Screening of pH and Additives
Na-citrate 3.0 100 mM NaCl, 0.25 M
sucrose, 0.01% Tween 80
Initial/no storage; 40◦C,
4 days; 2 mg/mLd
DLS, DSF
Glycine 3.5
Na-acetate 4.0
Na-acetate 4.5
Na-acetate 5.0
Succinate 5.5
Histidine 6.0
Histidine 6.5
Imidazole 7.0
Glycyl–glycine 8.0
Glycine 9.0
Glycine 10.0
Stability Studies Under Accelerated Storage Conditions
Na-citrate 3.3 100 mM NaCl, 0.25 M
sucrose, 0.05% Tween 80
Initial/no storage; 40◦C,
8 weeks; 12 mg/mLd
SAXSe, UV280 nm, SE-HPLC,
LabChip
Na-acetate 5.0
Histidine 6.5
Na-phosphate 7.4
Tris–HCl 8.5
Stability Studies Under Normal Storage Conditions
Histidinef 6.5 0.25 M sucrose Initial/no storage; 5◦C,
8 weeks; 25◦C, 8 weeks;
2 mg/mLd
SE-HPLC, iCE
Na-phosphateg 7.4 100 mM NaCl
aFinal concentration of the base buffers was 50 mM.
bMeasured at room temperature.
cExcipients were included respectively to each of the base buffers.
dAntibody concentration during storage.
eOnly the samples at initial time point were measured by SAXS.
fFormulation A.
gFormulation B.
Size-Exclusion HPLC
Protein samples in a wide range of different formulation buffers
(Table 1) were concentrated to approximately 12 mg/mL using
30,000 MWCO Amicon Ultra-4R© centrifugal filters (Millipore).
The samples were stored at 40◦C. After 8 weeks incubation, the
samples were centrifuged at 13,523 g for 10 min to remove pre-
cipitates. The remaining protein concentration was determined
based on A280. The samples representing normal storage con-
ditions at 5◦C and 25◦C were investigated in two formulations:
20 mM histidine (pH 6.5) containing 0.25 M sucrose (buffer
A) and 50 mM sodium phosphate (pH 7.4) containing 100 mM
NaCl (buffer B). The samples were exchanged into the formula-
tion buffers by using illustraTM NAPTM-5 Columns (GE Health-
care), and their concentrations were adjusted to 2 mg/mL.
These samples were stored at 5◦C and 25◦C, respectively, and
analyzed after 4 and 8 weeks, respectively. The amounts of
aggregates (high-molecular-weight species) and degradation
species (low-molecular-weight species, LMWS) were analyzed
by SE-HPLC using a G3000SWXL column (Tosoh Corporation,
Tokyo, Japan). The mobile phase consisted of PBS (Invitrogen,
Paisley, UK) and the flow rate was 0.8 mL/min. Twenty micro-
gram of antibody was injected in a volume of 10 :L. The UV
absorbance peaks were detected at 215 and 280 nm.
Small-Angle X-ray Scattering
The IgG antibodies were analyzed by SAXSwithout heat stress-
ing or long-term storage. The formulation setup is the same as
SE-HPLC analysis under accelerated storage conditions (Table
1). Before measurements, samples were diluted into concentra-
tion series, following beamline standard procedures.16 Samples
were centrifuged in a fixed angle rotor centrifuge at 15,871 g
for 10min immediately prior to measurement. The synchrotron
SAXS data were collected on beamline X33 at the European
Molecular Biology Laboratory on the DORIS III storage ring
(DESY, Hamburg, Germany). Samples were loaded using the
automated sample changer. Scattering from the IgG protein
solutions with concentrations between 1 and 12 mg/mL was
measured at 8◦C in the momentum transfer ranges of 0.07–5.0
nm−1 [s = 4Bsin(2)/8, where 22 is the scattering angle and 8 is
the X-ray wavelength (8= 1.5 A˚)]. Data analysis was performed
using the software suite ATSAS.16 In order to eliminate the im-
pact of structure factors,10 the low-concentration data of each
sample was merged with high-concentration data after super-
position of the curves in areas where scattering patterns were
identical for all concentrations. All SAXS curves were scaled
according to the curve of the same antibody in Na-phosphate
(pH 7.4) buffer with NaCl. The radius of gyration (Rg) and the
scattering intensity at zero angle I(0), for each sample was
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Figure 1. (a) Stability of antibodies investigated by SE-HPLC under accelerated storage conditions (40◦C for 8 weeks). LMWS indicate the
low-molecular-weight species. Blue, red, green, and pink trace lines indicate the samples at pH 5.0, 6.5, 7.4, and 8.5, respectively, containing
100 mMNaCl. The black trace line indicates the nonstressed sample at pH 7.4. (b) Stability of antibodies investigated by SE-HPLC under normal
storage conditions (5◦C or 25◦C for 8 weeks). Trace lines indicate the samples in Formulation A at 5◦C (cyan), Formulation A at 25◦C (pink),
Formulation B at 5◦C (blue), and Formulation B at 25◦C (green). Formulation A: 50 mM histidine, pH 6.5, 250 mM sucrose. Formulation B:
50 mM Na-phosphate, pH 7.4, 100 mM NaCl.
determined from the Guinier approximation. The pair distance
distribution functions, P(r), were evaluated using GNOM.17
RESULTS
Three humanized IgG subclasses, IgG1, IgG2, and IgG4, were
designed and expressed with identical anti-TNP CDRs, and pu-
rified to >99% purity, according to SE-HPLC profiles (Fig. 1a,
nonstressed samples). Glycan analysis (see SupplementaryMa-
terial) further revealed that the glycosylation patterns of the
three recombinant batches are essentially identical. This exper-
imental design enables an extensive systematic comparative
analysis of a number of solution conformation and stability pa-
rameters from the three different IgG subclasses. We show how
SAXS screening, applying robotics for the sample handling18
and semiautomated primary data analysis,19,20 readily pro-
vides valuable information about the antibody solution behav-
ior, which strongly complements the information available from
conventional analytical methods.
Characterization of Antibody Stability by Conventional Analytical
Methods
A comparison of the conformational stability of IgG1, IgG2, and
IgG4 was performed using thermally induced unfolding experi-
ments. The antibodies were investigated in the pH region 3–10,
monitored with DSF. As shown in Figure 2b, the thermal denat-
uration of the antibodies exhibited pH-dependent profiles and
the thermal stability increased dramatically from pH 3.0 to 5.5
for all three antibodies. The first transitions of IgG2 and IgG4
at pH 3.0 containing NaCl were not seen on the DSF curves, in-
dicating that the CH2 domains of these two subclasses unfold at
temperatures lower than 25◦C at this pH value. Because of the
nonspecific interactions of Tween 80with the SyproOrange dye,
no DSF data are available for Tween 80 formulations (data not
shown). The fluctuation at pH 6.0 on each line was because of
the influence of buffer species as previously reported.21,22 IgG1
showed the highest Tm values and hence exhibits the highest
thermal stability for the whole pH region tested, whereas the
presence of sucrose significantly improved the thermal stabil-
ity for all three subclasses. Both of these features are especially
evident at the lower pH values.
Using the exact same experimental conditions as for the DSF
analysis, the aggregation behavior was monitored by measur-
ing the Rh of the samples at the initial time point (data not
shown) and after storage at 40◦C for 4 days (Fig. 2c). In ac-
cordance with the observed effect of pH on the DSF analy-
sis, increasing aggregation was observed at lower pH, whereas
no changes were observed after storage above pH 5.0. Below
pH 5.0, IgG1 showed greatest resistance to aggregation and
its Rh value was only significantly increased at pH 3.0, hence
suggesting a potential link between conformational stability
and aggregation during storage. IgG2 showed higher Rh value
than IgG4 between pH 3.5 and 4.5. Sucrose significantly de-
creased aggregation of all IgG subclasses at low pH, which can
be explained by the theory of preferential hydration.23–25 In our
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Figure 2. (a) Primary structure of IgG1, IgG2, and IgG4 hinge regions (Kabat numbering14). (b) Tm measured by DSF and (c) Rh measured by
DLS at various pH values and by inclusion of various excipients. IgG1 (blue), IgG2 (red), and IgG4 (green). DLS measurements were performed
on stressed samples that were stored at 40◦C for 4 days.
studies, the nonionic surfactant Tween did not significantly re-
duce aggregation.
Accelerated studies, probing the physical and chemical sta-
bility of the antibodies under a number of experimental con-
ditions (Table 1), were assessed by UV280 nm, SE-HPLC, and
LabChip (see Supplementary Material). The samples were
heat-stressed at 40◦C for 8 weeks. SE-HPLC quantitatively
measures the aggregates, dimers, and fragments of antibod-
ies, whereas LabChip was employed to investigate the frag-
mentation within the domains and the nonreducible chemical
cross-linking. Because of the aggregation and precipitation, the
SE-HPLC and LabChip profiles of the samples at pH 3.3 are
not available (Supplementary Fig. S3a). As shown in Figure 1a,
the SE-HPLC elution profiles of the other samples clearly re-
vealed the presence of soluble aggregates, dimers, monomers,
and fragments. Significant differences between subclasses were
observed. The amount of soluble aggregates and dimers of IgG4
increased more than for IgG1 and IgG2 at pH 8.5, as well as in
the presence of Tween 80 (Supplementary Fig. S3b). Aggrega-
tion levels of all IgG subclasses exhibited pH dependence with
the highest stability in the histidine buffer at pH 6.5, which is
indeed frequently chosen when developing protein formulation
in the pharmaceutical industry.21,26 In the entire pH range stud-
ied, more fragments were formed by IgG1 (Fig. 1a), resulting
in the fragmentation profiles IgG1 > IgG2 > IgG4 at the same
formulation conditions (i.e., IgG4 being the most stable). Frag-
mentation did not significantly differ among additives tested
(Supplementary Fig. S3b). The fragmentation of antibodies ob-
served at pH 5.0, 6.5, and 7.4 was qualitatively similar to those
reported by others.26,27 However, the larger pH range studied
here revealed the most significant differences in fragmentation
at pH 8.5.
Antibody storage stability after 8 weeks at 5◦C and 25◦Cwas
further studied in two buffers. On the basis of the DLS and SE-
HPLC results in accelerated stability studies at 40◦C, aggrega-
tion is decreased in the presence of sucrose (Fig. 2c), whereas
fragmentation is lowered in histidine buffer (Fig. 1a), hence
20 mM histidine at pH 6.5 containing 0.25 M sucrose is se-
lected as an optimized formulation (Formulation buffer A). Na-
phosphate (50 mM) pH 7.4 containing 100 mMNaCl (Formula-
tion buffer B), which is commonly used in biological research, is
selected for comparison. No aggregation or fragmentation was
observed by SE-HPLC (Fig. 1b) and LabChip analysis (Sup-
plementary Information) for any of the samples stored at 5◦C
(Fig. 1b). At 25◦C, insignificant amounts of fragments for IgG2
and substantial amounts for IgG1 were observed (Fig. 1b). Ac-
cording to the fragmentation profiles, the antibodies are more
stable in Formulation A and IgG4 exhibited the best stability.
Combined with results from accelerated studies, all three IgG
subclasses exhibit similar profiles in terms of aggregation at
pH 6.5 (Figs. 1a and 1b), thus antibody fragmentation becomes
the dominant consideration when comparing IgG subclasses at
this pH. Considering that larger particles might be lost when
measuring by SE-HPLC, DLS was also employed to investigate
aggregation. No differences were observed in the Rh for any of
the samples (data not shown).
In conclusion, the physical stability in terms of aggregation
can be ranked IgG1>IgG4>IgG2 below pH 5.0, whereas IgG1
> IgG2 > IgG4 above pH 5.0. The chemical stability in terms
of fragmentation can be ranked IgG4 > IgG2 > IgG1 at all
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Figure 3. (a) Comparison of the SAXS curves at different pH. The SAXS curves of the samples at pH 3.3, pH 5.0, pH 6.5, pH 7.4, and pH 8.5
are translated for comparison and ordered sequentially from top to bottom for each IgG (i.e., within each color). (b and c) The P(r) of the samples
at pH 6.5 and pH 3.3 from the indirect Fourier transformation of the scattering intensity. (d–f) Kratky plots based on the SAXS data of IgG1,
IgG2, IgG4, respectively, at pH 6.5 and 3.3.
of the formulation conditions investigated (pH, additives, and
temperatures).
Solution Behavior of Antibodies Investigated by SAXS
According to thermal stability analysis by conventional bio-
physical methods, the antibodies exhibit significant differences
in terms of aggregation amongst pHs, additives, and subclasses.
In order to further investigate the solution behavior of antibod-
ies at the initial time point, SAXS was employed. We used the
same formulation setup as for SE-HPLC analysis in acceler-
ated stability studies (Table 1) but without heat stressing or
long-term storage. Considering that the antibodies are prone
to aggregate at low pH, the low pH samples were measured im-
mediately after exchanging the buffer into 50 mM Na-citrate
(pH 3.3).
The experimental SAXS curves from the samples containing
NaCl are shown in Figure 3a. From the indirect Fourier trans-
formation of the scattering data,17 the P(r) of the antibodies in
solution is obtained (Fig. 3b), and from the slightly different
shapes it is evident that subtle differences exist in the overall
solution conformation between different subclasses. From the
P(r), the maximal dimension (Dmax) of the solute species is also
estimated. Dmax is comparable for all three subclasses, yet the
larger dimensions are on average reached more often by the
IgG1 molecules [as seen by a small right-shift of the P(r) curve
for IgG1]. Indeed, IgG1 has a longer hinge region than IgG2
and IgG4 (Fig. 2a), and thus may either have a more extended
conformation or greater overall flexibility in solution. Accord-
ingly, IgG1 reveals slightly higher Rg values than the other
IgGs (with the exception of the partially dimerized samples at
low pH, Fig. 4a). The differences between these curves are all
reflections of the IgG subclass variation with respect to solution
conformation(s). These differences can be investigated further
and potentially modeled, but this is beyond the scope of this
publication.
However, within each antibody subclass, all SAXS curves are
similar from pH 5.0 to pH 8.5 (Fig. 3a), which indicates that
each antibody has the same overall conformation in this pH
region. In contrast, at pH 3.3, both IgG2 and IgG4 exhibit sig-
nificantly different SAXS curves and subclass differences are
also more evident (Fig. 3c). Including also the comparison of
Kratky plots at pH 6.5 and 3.3 for each of the three subclasses
(Figs. 3d–3f), it is evident that larger scatterers appear in the
IgG2 and IgG4 low pH solutions. The overall size of these larger
scatterers are well-resolved within the resolution range (a peak
at low angles is clearly resolved), which shows that samples
are devoid of large (unspecific) aggregates. In contrast, in the
presence of large aggregates, the curves would have revealed a
pronounced increase in scattering intensity in this region. The
Rg calculated from the Guinier region of the SAXS curve, shows
the increased sizes in IgG2 and IgG4 (Fig. 4a). In addition, the
extrapolated I(0) is proportional to the molecular mass of the
protein,28 thus (partial) oligomerization or aggregation will in-
crease I(0). At almost all experimental conditions investigated,
the calculated MW is as expected for the monomeric antibody
with only one remarkable difference: the I(0) values of IgG2 and
IgG4 at pH 3.3 with NaCl were nearly doubled compared with
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Figure 4. (a) Rg of three IgG subclasses in different formulation buffers and (b) the corresponding I(0) values. 1–5 on x-axis indicate the samples
at pH 3.3, 5.0, 6.5, 7.4, and 8.5, respectively, containing 100 mM NaCl. 6–10 indicate the samples at pH 3.3, 5.0, 6.5, 7.4, and 8.5, respectively,
containing 250 mM sucrose. 11 indicate the samples at pH 7.4 containing 0.05% Tween 80. (c and d) Concentration dependence of the three
antibodies in Na-citrate buffer (pH 3.3). The data curves of the individual IgGs have been transposed for clarity. (e and f) SAXS curves comparing
the effect of sucrose and NaCl at pH 6.5 and 3.3. Dimerization is observed at pH 3.3 for IgG2 and IgG4. The data curves of the individual IgGs
have been transposed for clarity.
measurements at other pH values (Fig. 4b). Also, there are no
notable effects on I(0), and thus the average oligomeric state,
when varying the total protein concentration (Figs. 4c and 4d).
In conclusion, the increased MW of IgG2 and IgG4 at pH 3.3
is because of the specific dimerization at early time point after
buffer exchange. Within the time-range observed, there are no
signs of further oligomerization or aggregation in any of the
samples investigated.
The SAXS curves of the samples at pH 3.3 and pH 6.5 with
different additives are compared in Figures 4e and 4f. IgG2 and
IgG4 dimerization at pH 3.3 was significantly decreased by the
addition of sucrose. Likely, this is because of the preferential ex-
clusion effects.29 Mosbaek et al.10 reported that repulsion was
the dominating interparticle effect in IgG2 samples with su-
crose at protein concentrations below 38 mg/mL. According to
the concentration series at pH 3.3 measured in this analysis
(Figs. 4c and 4d), similar repulsion was observed for all IgG
samples with sucrose. The repulsion reduces the proximity of
the molecules and thus improves the colloidal stability of the
antibodies. The SAXS curves for all subclasses at pH 6.5 ex-
hibit only minor differences between sucrose and NaCl formu-
lations, which can be systematicallymodeled by a constant scat-
tering contribution derived from solvent interactions.30 Thus,
there is no evidence for conformational differences in the ab-
sence/presence of sucrose.
DISCUSSION
The selection of the right antibody format for a drug candi-
date is not only a question of targeting the right effector func-
tions suitable for the biological system. Stability of the IgG
subclass is also an important factor that can have significant
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impact both for manufacturing and for drug product formula-
tion. In this study, we have performed extensive comparative
analysis of three subclasses of monoclonal IgGs by character-
izing their solution behavior, structural, conformational, and
colloidal stability. The design of recombinant humanized IgG1,
IgG2, and IgG4 with identical CDRs gives unique insights into
antibodies of merely different IgG constant composition. The
three IgG subclasses were produced using identical purifica-
tion protocols, and our size-exclusion chromatographic control
and glycan analysis reveal samples of high purity and quality.
This experimental design hence enables a hitherto high level of
qualitative and quantitative comparisons of solution properties
of this therapeutically important class of molecules.
Of particular relevance is the improvement of existing and
development of novel means to screen various stability param-
eters in a high-throughput fashion. Several chemical and phys-
ical degradation pathways influence protein stability31 and ide-
ally therapeutical antibodies must be investigated by several
techniques and under many different formulation conditions.
In this study, we reveal how SAXS-based scanning of the so-
lution behavior of IgG subclasses clearly complements the in-
formation, which may be retrieved by other well-established
biophysical screening methods.
Comparative Analysis of IgG Subclasses Employing Conventional
Biophysical Analysis
In this study, we compare how different methods probe dif-
ferent parameters, which are important for the assessment of
stability of biopharmaceuticals. The comparison is based on
the observations reported here, hence variations may be seen
if applying the methods to a different type of proteins or other
macromolecules. Some general conclusions can be drawn ac-
cordingly. DLS is a very sensitive method to detect the forma-
tion of aggregates in a qualitative manner directly in a given
formulation as well as study the colloidal stability.32 The ther-
mal stability studied with DSF monitors the conformational
stability and interprets the folding–unfolding pathway. It pro-
vides an important initial assessment of stability but cannot
reliably predict oligomerization, aggregation, and other degra-
dation under long-term storage conditions. Fragmentation is
readily monitored by HPLC and LabChip (see Supplementary
Material). HPLC is also highly useful for determining the de-
gree of oligomerization and to some extent monitors soluble
aggregation. iCE could not provide detailed information about
any specific degradation without further characterization, but
an overall profile of chemical stability could be sensitively in-
vestigated by comparing charge-related heterogeneity (see Sup-
plementary Material).
Subtle differences between subclasses are, however, only re-
vealed when applying all the methods in concert. As an ex-
ample, acid-induced aggregation was monitored by combining
DSF, DLS, and SE-HPLC. Low pH treatment is commonly used
in the virus inactivation process or affinity purification of mon-
oclonal antibodies, and we show that IgG subclasses exhibit
different aggregation propensity because of differential stabil-
ity of the corresponding CH2 domain in the Fc region.33 In our
studies, DSF data further demonstrated higher conformational
stability of IgG1, compared with IgG2 and IgG4, below pH 5.0
and accordingly IgG1 is more resistant to low pH aggregation
as observed by DLS (Fig. 2c). It is known, in addition, that pH
shifts can be used as a chemical stressor, which reproducibly
generate artificial aggregates that behave similarly to native
ones.34 Antibodies are also prone to fragmentation at acidic
pH,35 whereas in our studies all the samples entirely precipi-
tated at pH 3.3 under accelerated storage conditions.
When comparing the large body of data produced in this
study, it provides an overall assessment of the conformational
and colloidal stability of the individual IgG subclasses. In
brief, IgG1 is much more susceptible to fragmentation (Fig. 1),
whereas possessing a higher overall conformational stability
(Fig. 2b) and a lower tendency to oligomerize and aggregate
(Figs. 1 and 2c). Both conformational and colloidal stability are
compromised at the lowest pH value investigated (pH 3.3), par-
ticularly for IgG2 and IgG4, whereas the greatest overall stabil-
ity is achieved around pH 6.5 (Fig. 1a; Supplementary Fig. S4e).
Sucrose increases the conformational stability and hinders ag-
gregation (Fig. 2), whereas fails to rescue the observed chemical
degradation (Supplementary Figs. S3b and S4d). Tween is an
often used excipient36,37 in the pharmaceutical industry in order
to protect against mechanical stress; however, the few samples
investigated in the current study do not reveal increased confor-
mational or colloidal stability in the presence of this surfactant
at static conditions (not all data are shown).
Complementary Information About IgG Solution Behavior from
High-Throughput Compatible SAXS Screening
Small-angle X-ray scattering analysis is not yet a standard
method for formulation development in the biopharmaceutical
industry, although it is rapidly increasing in use in biomedi-
cal research, not the least because of significant advances of
dedicated beamlines,38–40 advanced and user-friendly semiau-
tomated software,16,20 and robust in-house equipment.41 SAXS
can be employed for detailed advanced structural characteri-
zation of the investigated biomacromolecules,42 and can thus
also be used for refined structural modeling (not presented in
this paper). However, SAXS may also be employed in a high-
throughput screening setup, focused on initial primary analy-
sis of basic biophysical characteristics, to which SAXS is very
sensitive. The sample consumption for SAXS analysis is con-
tinuously diminishing. The current standard screening setup
at advanced synchrotron beamlines demands sample volumes
of approximately 10 :L,38 and further development toward sub-
microliter consumption is on-going.43 Also, in-house BioSAXS
equipment developed for the analysis of biological samples is
becoming increasingly affordable and can be installed with a
high level of automation, which attracts more and more inter-
est, also from pharmaceutical companies.
In the current study, we employ SAXS to screen the solution
behavior without heat stressing and prior to long-term stor-
age. Interestingly, IgG1 exhibits slightly larger particle size
than IgG2 and IgG4 (Fig. 4a) in a broad pH range (5.0–8.5),
which is in accordance with DLS results (Fig. 2c). In addition,
an identical solution conformation was identified in this pH
range for individual IgG subclass by SAXS, whereas subtle dif-
ferences among three IgG subclasses were sensitively detected
(Fig. 3b). Finer differences in the conformational selectivity of
IgG subclasses may potentially be modeled in the future. At
pH 3.3, dimerization resulting from buffer exchange was sen-
sitively detected for IgG2 and IgG4 before subjecting to heat
stress. The samples were freshly prepared and quickly mea-
sured by SAXS, thus indicate that the antibody dimerization
initiates rapidly after buffer exchange. This may be triggered
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by acid-induced CH2 unfolding associated with the protona-
tion of specific acidic residues.44 Salt may be an accelerating
factor of antibody aggregation at acidic pH by reducing the
charge repulsion.45 Sucrose significantly increases physical sta-
bility of all three IgG subclasses, likely because of preferential
hydration.25 Detailed analysis of the concentration dependence
(Figs. 4c and 4d) demonstrated that IgG1 has increased repul-
sive protein–protein interactions at pH 3.3 with NaCl, which
might protect IgG1 against initial dimerization and later un-
specific aggregation. This effect is comparable to the general ef-
fect of sucrose on all IgG subclasses (Fig. 4d). These differences
at acidic pH are in agreement with the differences observed
by conventional DLS. However, conventional biophysical tech-
niques failed to describe the nature of the oligomeric state and
the intermolecular interactions. SAXS is much more sensitive
with respect to detection of oligomerization and is therefore
used to describe the solution behavior as well as changes at dif-
ferent formulation conditions. In addition, SAXS can provide
unique conformational information that potentially enables us
to rationalize the functional and physicochemical properties of
IgG antibodies.
A Glimpse of the Future Potential of SAXS-Based Formulation
Screening
In our study, SAXS reveals differences in solution behavior at
initial time points, sensitive to excipient differences and in a
subclass specific manner. SAXS might therefore develop into a
fast screening method for selection of the most robust molecule
because of the detection and description of differences at early
time points in contrast to more conventional methods that de-
tected differences only after a given period of time. SAXS may
be applied under virtually any relevant formulation conditions
without introducing any solvent disturbance or further sample
treatment during measurement, which is a powerful asset of
the technique. As an example, it is noteworthy that although
the presence of Tween complicates several of the standard bio-
physical analysis types, SAXS readily addresses the solution
behavior in the presence of Tween, both in the current and
previous studies.10
Although we did not observe significant conformational dif-
ferences in the pH range of 5.0–8.5 and between NaCl and
sucrose, it is possible to investigate the effects of pH and ex-
cipients on antibody solution behavior under an appropriate
stressing condition, for example, temperature, pH, denaturant,
and so on, as exemplified by our studies at acidic pH. Such
studies would give further information about the level of ro-
bustness of the respective molecules. At the moment, we have
not applied SAXS measurements under other stressing condi-
tions, although clearly it is possible to use SAXS for accelerated
stability studies. Antibodies are often formulated at very high
protein concentrations. It has previously been presented that
SAXS readily addresses antibody solution behavior in high-
concentration samples.10
CONCLUSIONS
Small-angle X-ray scattering characterization could strongly
support selection or development of the therapeutic molecule
as well as being part of formulation development of antibodies,
or any other therapeutic protein drug candidate. It is empha-
sized that only primary analysis of the data is necessary to
reach the conclusions presented here. For well-behaving sam-
ples, the analysis of different formulations can be performed in
a semiautomated manner20 using automated sample changer.
It is thus possible to use such SAXS-based formulation screen-
ing in a high-throughput setup at early stages of formulation
development.
Potential transient and/or stable protein–protein interac-
tions at different formulation conditions may also be studied,
and it is possible to clearly distinguish levels of oligomerization.
An interesting hardware development within solution SAXS
analysis is the coupling of FPLC and SAXS measurements,46
which enables quantitative SAXS analysis directly from pu-
rified samples, hence addressing, for example, the nature of
oligomerization equilibria and offers assessment of the type of,
for example, higher-order oligomerization.
If further structural information is requested for particu-
lar solution conditions, more advanced data analysis can be
applied.47 As an example, a recent study on IgG1 reveals a
conformational equilibrium in solution, and a shift toward
an “open” conformation was identified under altered solution
conditions.48 Likewise, our studies revealed subtle conforma-
tional differences among the three IgG subclasses (Fig. 3b),
which might correlate to their differential physical stability.
Further studies by advanced structure modeling are on-going.
In this study, however, it suffices to demonstrate the high de-
gree of complementarity in the information derived from SAXS-
based scanning in a comparative study of IgG subclass solution
behavior and stability.
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